Advancing sample preparation: A novel composite technology for enhanced solid phase extraction (SPE)

Solid-phase extraction (SPE) is the gold standard for sample preparation in chromatographic analysis. It is used to capture, clean, and concentrate samples while removing interfering compounds, helping users attain reliable and sensitive chromatographic data.

Conventionally, SPE products are loose packed with active resin between porous frits. However, these products suffer from inconsistent resin mass, channeling, and voiding which can reduce recovery and result in poor reproducibility.

The Microlute® CSi products utilize a novel composite technology with a mixture of porous plastic and chromatographic SPE resin, designed to eliminate the issues caused by the loose packing of SPE products.

The following experiment compares SPE results from a C18 10 mg loose packed plate with a C18 10 mg composite plate (Microlute® CSi), both created using the same batch of C18 resin.

Schematic illustration of composite technology

Figure 1. Schematic illustration of the composite technology. Image Credit: Porvair Sciences Limited

Methodology

A range of compounds consisting of acidic, basic, and neutral analytes were selected based on their intrinsic physical and chemical properties, such as pKa and LogP. Testing with a wide range of compounds enabled a more detailed comparison between each plate format.

Six replicates were tested from each compound class using a suitable SPE method.

The SPE followed a typical 10 mg reversed-phase method: condition: 500 µL MeOH; equilibration: 500 µL of H2O; load: 500 µL sample (pH adjusted to neutralize any charge on acidic and basic compounds); wash: 500 µL of H2O; elute: 2 x 250 µL MeOH (pH adjusted to charge the acidic and basic compounds).

The eluted samples were dried and reconstituted before being analyzed with an Agilent 1260 HPLC attached to an Agilent Single Quadrupole MSD.

Table 1. Properties of the analytes used in testing 1. Source: Porvair Sciences Limited

Compound LogP pKa Analyte Type
Atenolol 0.16 9.60 Basic
Pindolol 1.75 9.25 Basic
Dexamethasone 1.83 -3.30, 12.42 Neutral
Corticosterone 2.09 -0.26, 13.86 Neutral
Carbamazepine 2.77 -3.80, 15.96 Neutral
Ketoprofen 3.12 4.45 Acidic
Naproxen 3.18 4.15 Acidic
Niflumic acid 4.43 5.30 Acidic
Propranolol 3.48 9.42 Basic
Nortriptyline 3.90 9.70 Basic
Desipramine 4.90 10.40 Basic

 

Results and discussion

Recovery

The results demonstrated that both plates performed well in analyte recovery across all 11 compounds. Average recoveries of 91% for the composite and 88% for the loose packed plates validate the utility of the SPE technique in sample preparation for chromatography.

Percent recovery for each analyte using an average recovery calculated from six replicates.

Figure 2. Percent recovery for each analyte using an average recovery calculated from six replicates. Image Credit: Porvair Sciences Limited

Reproducibility

The difference in reproducibility between the two plates was substantial; a significant improvement was evident when using the composite plate.

This could be demonstrated by calculating an average percentage for relative standard deviation (%RSD) across the compounds tested. The loose packed plate had an RSD of approximately 6%, while the composite plate had an RSD of less than 2% (Microlute® CSi).

Percent relative standard deviation for recovery for each analyte using six replicates.

Figure 3. Percent relative standard deviation for recovery for each analyte using six replicates. Image Credit: Porvair Sciences Limited

Figure 3 shows the composite silica plate had markedly higher reproducibility for all 11 compounds tested. Poorer recovery and reproducibility in the loose packed plate can be attributed to inconsistencies in the packing of chromatographic media, which is inherent to this process (Figure 4).

The unique immobilization technology used in Microlute® CSi guarantees consistent bed weights and optimal liquid flow through every well, plate after plate. This leads to predictable interaction of solutions and analytes with the active chromatography resin.

Common problems with traditional loose packed products.

Figure 4. Common problems with traditional loose packed products. Image Credit: Porvair Sciences Limited

Conclusion

The 10 mg Microlute® CSi C18 composite silica plate for SPE offered excellent reproducibility and recovery for all the compounds assessed in this study. The uniformity of the composite technology enables an even distribution of active media and maximizes interactions throughout the structure, resulting in exceptionally reproducible data.

The novel composite format enhances recovery and can provide up to three times better reproducibility than the traditional loose packed plate formats.

Acknowledgments

Produced from materials originally authored by James Edwards from Porvair Sciences.

References and further reading

Drugbank, [Online]. Available at: https://go.drugbank.com/ (Accessed 2024)

About Porvair Sciences

Porvair Sciences, specialists in the manufacture of microplate products, serve Life Sciences, Biotechnology, R&D and Molecular Biology with microplate solutions for all applications, from sample preparation to high throughput screening via our global distributor network.

Our range includes vacuum manifolds, sealers, evaporators and microtiter plates in all popular styles; deep well and shallow well storage plates, assay plates, luciferase reporter gene plates and liquid handling reagent reservoirs. We also provide custom microplate products for life science research. Our vacuum manifolds, essential for 96-well SPE sample preparation, are designed to work with most popular filter plates, including Waters, Millipore, Qiagen, Whatman, GE Healthcare, Varian, Biotage and, of course, Porvair.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Aug 28, 2024 at 4:37 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Porvair Sciences Limited. (2024, August 28). Advancing sample preparation: A novel composite technology for enhanced solid phase extraction (SPE). News-Medical. Retrieved on September 14, 2024 from https://www.news-medical.net/whitepaper/20240828/Advancing-sample-preparation-A-novel-composite-technology-for-enhanced-solid-phase-extraction-(SPE).aspx.

  • MLA

    Porvair Sciences Limited. "Advancing sample preparation: A novel composite technology for enhanced solid phase extraction (SPE)". News-Medical. 14 September 2024. <https://www.news-medical.net/whitepaper/20240828/Advancing-sample-preparation-A-novel-composite-technology-for-enhanced-solid-phase-extraction-(SPE).aspx>.

  • Chicago

    Porvair Sciences Limited. "Advancing sample preparation: A novel composite technology for enhanced solid phase extraction (SPE)". News-Medical. https://www.news-medical.net/whitepaper/20240828/Advancing-sample-preparation-A-novel-composite-technology-for-enhanced-solid-phase-extraction-(SPE).aspx. (accessed September 14, 2024).

  • Harvard

    Porvair Sciences Limited. 2024. Advancing sample preparation: A novel composite technology for enhanced solid phase extraction (SPE). News-Medical, viewed 14 September 2024, https://www.news-medical.net/whitepaper/20240828/Advancing-sample-preparation-A-novel-composite-technology-for-enhanced-solid-phase-extraction-(SPE).aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.